Yi-Mi, W., Cieslik, M., Lonigro, R. J., Pankaj, V., Reimers, M. A., Xuhong, C., . . . Chinnaiyan, A. M. (2018). Inactivation of CDK12 delineates a distinct immunogenic class of advanced prostate cancer. Cell.
Chicago ZitierstilYi-Mi, Wu, et al. "Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer." Cell 2018.
MLA ZitierstilYi-Mi, Wu, et al. "Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer." Cell 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.